| Literature DB >> 26474241 |
Yuanyuan Yue1, Qiao Dong2, Yajie Zhang2, Xiaoge Li2, Xuyang Yan2, Yahui Sun2, Jianming Liu2.
Abstract
Small molecular drugs that can combine with target proteins specifically, and then block relative signal pathway, finally obtain the purpose of treatment. For this reason, the synthesis of novel imidazole derivatives was described and this study explored the details of imidazole derivatives binding to human serum albumin (HSA). The data of steady-state and time-resolved fluorescence showed that the conjugation of imidazole derivatives with HSA yielded quenching by a static mechanism. Meanwhile, the number of binding sites, the binding constants, and the thermodynamic parameters were also measured; the raw data indicated that imidazole derivatives could spontaneously bind with HSA through hydrophobic interactions and hydrogen bonds which agreed well with the results from the molecular modeling study. Competitive binding experiments confirmed the location of binding. Furthermore, alteration of the secondary structure of HSA in the presence of the imidazole derivatives was tested.Entities:
Keywords: Human serum albumin; Imidazole derivatives; Molecular modeling; Quenching mechanisms
Mesh:
Substances:
Year: 2016 PMID: 26474241 DOI: 10.1016/j.saa.2015.09.023
Source DB: PubMed Journal: Spectrochim Acta A Mol Biomol Spectrosc ISSN: 1386-1425 Impact factor: 4.098